<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2811211383
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2006
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        AMLOPRESS 5MG CAPSULES
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AMLODIPINE BESILATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Capsule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        28
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        32.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C08CA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>AMLOPRESS&reg; belongs to a group of medicines called calcium antagonists.</p><p><strong>AMLOPRESS&reg; are used to treat:</strong></p><p>-&nbsp;&nbsp;&nbsp; High blood pressure</p><p>-&nbsp;&nbsp;&nbsp; Chest pain due to narrowing of the blood vessels of the heart muscle (angina pectoris) or the more rare form of chest pain caused by cramping of the blood vessels of the heart muscle.</p><p>If you suffer from high blood pressure, AMLOPRESS&reg; works by relaxing blood vessels, so that blood passes through them more easily.</p><p>If you suffer from angina, AMLOPRESS&reg; works by improving blood supply to the heart muscle which then receives more oxygen and as a result chest pain is prevented. AMLOPRESS&reg; does not provide immediate relief of chest pain from angina.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take AMLOPRESS&reg;, If you</strong></p><p>-&nbsp;&nbsp;&nbsp; are allergic to AMLOPRE55&reg;or similar calcium channel blockers (the so-called Dihydropyridine derivates like felodipine, nifedipine, nimodipine) or to any of the other ingredients (for a full list of ingredients, see section 6).</p><p>-&nbsp;&nbsp;&nbsp; are suffering from cardiogenic shock. This is a condition where the heart is unable to pump sufficient blood around the body. The symptoms of cardiogenic shock are low blood pressure, low pulse and fast heartbeat.</p><p>-&nbsp;&nbsp;&nbsp; are suffering from narrowing of the aorta (aortic stenosis).</p><p>-&nbsp;&nbsp;&nbsp; suffer from chest pain at rest or with minimal effort (unstable angina pectoris).</p><p>-&nbsp;&nbsp;&nbsp; are pregnant or breast-feeding.</p><p>-&nbsp;&nbsp;&nbsp; have severe low blood pressure.</p><p><strong>Take special care with AMLOPRESS&reg;</strong></p><p><strong>Before taking AMLOPRESS&reg;, tell your doctor If you</strong></p><p>-&nbsp;&nbsp;&nbsp; have heart failure or have suffered a heart attack during the past month.</p><p>-&nbsp;&nbsp;&nbsp; have liver problems</p><p>-&nbsp;&nbsp;&nbsp; are giving this medicine to a child under 18 years of age</p><p>-&nbsp;&nbsp;&nbsp; are elderly, your doctor may monitor you closely.</p><p><strong>Taking other medicines</strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>Some medicines (including medicines obtained without prescription, herbal medications or natural products) may interact with AMLOPRESS&reg;. This means that the action of both medicines can be changed.</p><p>In particular, tell your doctor if you are taking any of the following medicines:</p><p>-&nbsp;&nbsp;&nbsp; Medicines that can lower blood pressure (e.g. verapamil, diltiazem)</p><p>-&nbsp;&nbsp;&nbsp; Katoconazole and Itraconazole (antifungal medicines used to treat sldn and fungal Infections)</p><p>-&nbsp;&nbsp;&nbsp; HIV-protease-inhibitors (antiviral medicines used to treat HIV infections, e.g. ritonavir)</p><p>-&nbsp;&nbsp;&nbsp; Clarithromycin, erythromycin and telithromycin, rifampicin, rifabutin (antibiotics)</p><p>-&nbsp;&nbsp;&nbsp; Nefazodone (medicine to treat depression)</p><p>-&nbsp;&nbsp;&nbsp; St. John&rsquo;s wort (Hypericum perforatum; herbal medicine for depression)</p><p>-&nbsp;&nbsp;&nbsp; Dexamethasone (corticosteroid used to treat inflammatory and autoimmune conditions such as rheumatoid arthritis)</p><p>-&nbsp;&nbsp;&nbsp; Phenobarbital, phenytoin and carbamazepin (medicines for epilepsy)</p><p>-&nbsp;&nbsp;&nbsp; Nevirapine (antiviral medicine used to treat HIV and AIDS)</p><p>-&nbsp;&nbsp;&nbsp; Sildenafil (medicine for impotence)</p><p><strong>Children</strong></p><p>Safety and effectiveness have been studied in 6-17 year old boys and in girls. An AMLOPRESS&reg; has not been studied in children under the age of 6 years. If you need more information, talk to your doctor.</p><p><strong>Taking AMLOPRESS&reg; with food and drink</strong></p><p>AMLOPRESS&reg; should be taken with a glass of liquid (e.g. a glass of water) with or without food.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>You should not take this medicine if you are pregnant or breastfeeding. If you are of child bearing age, you should ensure that you use effective contraceptive protection during your treatment. If you become pregnant whilst taking these, contact your doctor immediately for advice.</p><p>Ask your doctor or pharmacist for advice before taking any medicine.</p><p><strong>Driving and using machines</strong></p><p>Some patients may experience side effects such as dizziness, sleepiness or blurred vision whilst taking these Capsules (see section 4 of this leaflet). Such side effects are more likely to occur at the start of treatment or following an Increase In dose. If you suffer from these effects, you should not drive or perform other activities that require you to be alert.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Dosage</strong></p><p>Always take AMLOPRESS&reg; exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p><strong>Methods and routes of administration</strong></p><p>Swallow the Capsule with a glass of water. Do not chew. You can take them with or without food.</p><p><strong>Adults</strong></p><p>The usual starting dose is 5 mg once daily. If necessary, your doctor may increase the dose to 10 mg once daily.</p><p><strong>Children (6 -17 years old)</strong></p><p>The recommended usual starting dose is 2.5 mg a day. The maximum recommended dose is 5 mg a day.</p><p>AMLOPRESS&reg; 2.5 mg is not currently available and the 2.5 mg dose cannot be obtained with AMLOPRESS&reg;5 mg as these Capsules are not manufactured to break into two equal halves.</p><p><strong>Elderly patients</strong></p><p>There is no special dosage for the elderly; however, care must be taken when the dose is increased.</p><p><strong>If you have kidney problems</strong></p><p>The normal dosage is recommended. AMLOPRESS&reg; cannot be removed from the blood by dialysis (artificial kidney). AMLOPRESS&reg; should be administered with particular caution to patients undergoing dialysis.</p><p><strong>If you have liver problems</strong></p><p>Your doctor will decide if this medicine is suitable for you and the correct dose tor you to take.</p><p><strong>If you take more AMLOPRESS&reg; than you should</strong></p><p>If you or someone else has taken too much AMLOPRESS&reg;, contact your nearest hospital casualty department. Please carry with you the product leaflet or remaining Capsule tor better identification of the doctor. The person concerned should be made to lie down with their arms and legs up (resting on a couple of cushions, for example). Symptoms of an overdose are:</p><p>Extreme dizziness and/or feeling very light-headed, problems with breathing, having to urinate very often.</p><p>Excess fluid may accumulate in your lungs )pulmonary oedema( causing<br />shortness of breath that may develop up to 24-48 hours after intake.</p><p><strong>If you forget to take AMLOPRESS&reg;</strong></p><p>If you have forgotten to take AMLOPRESS&reg; capsule, you can still take it up to 12 hours after you usually take your capsule. If It Is more than 12 hours after the time that you should have taken the capsule, you should not take the missed dose and you should take the next capsule at the usual time. Never take a double dose of AMLOPRESS&reg; to make up for the dose that you have missed.</p><p><strong>If you stop taking AMLOPRESS&reg;</strong></p><p>Your doctor has told you how long you should take AMLOPRES5&reg;. If you stop the treatment suddenly, your symptoms may come back. Do not stop the treatment earlier than agreed without discussing this with your doctor.</p><p>An AMLOPRESS&reg; is usually used for long term treatment.</p><p><strong>If you have any further questions on the use of this product, ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, AMLOPRESS&reg; can cause side effects, although not everybody gets them.</p><p>Tell your doctor immediately if you experience any of the following symptoms after taking this medicine. Although they are very rare, the symptoms can be severe.</p><p>&bull;&nbsp;&nbsp;&nbsp; Sudden wheeziness, difficulty in breathing, swelling of eyelids, face or lips, rash or itching (especially affecting the whole body).</p><p>The following side effects have been observed during treatment with AMLOPRESS&reg;:</p><p><strong>Very common (Occurring in more than 1 in 10 patients treated)</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Swollen ankles</p><p><strong>Common (Occurring in less than 1 in 10, but more than 1 in 100 patients treated)</strong></p><p>&bull;&nbsp;&nbsp;&nbsp; Headache (especially at the beginning of treatment), sleepiness, dizziness, weakness</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; a quicker or irregular heartbeat, nausea, digestive problems, stomach pain</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Facial redness and feeling hot (especially at the beginning of treatment)</p><p><strong>Uncommon (Occurring in less than 1 in 100, but more than 1 in 1000 patients treated)</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Enlarged breasts in men</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Sleep disorders, irritability, depression</p><p>&bull;&nbsp;&nbsp;&nbsp; Feeling unwell, dry mouth, uncontrolled shaking, pins and needles, increased sweating</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Problems with your eye-sight (visual disturbances)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Ringing or buzzing in the ears</p><p>&bull;&nbsp;&nbsp;&nbsp; Fainting, increased heart rate, chest pain, aggravation of angina may occur at the beginning of the treatment</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Low blood pressure, inflammation of the blood vessels</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Breathing difficulties, Inflammation of the nasal mucosa, cough</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Vomiting, diarrhoea, constipation, swollen gums</p><p>&bull;&nbsp;&nbsp;&nbsp; Prickling and tingling sensation of the skin, itching, nettle rash, hair loss, discolouration of the skin</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Muscle cramps, back pain, muscle and joint pain</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Increased need to urinate</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Impotence, enlargement in breast size of males.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Increase or decrease in weight</p><p><strong>Rare (Occurring in less than 1 in 1000, but more than 1 in 10000 patients treated)</strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Confusion, mood changes including anxiety</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Change in taste</p><p>&bull;&nbsp;&nbsp;&nbsp; Increase of certain liver enzymes; yellowing of the skin or whites of the eyes, this could be the result of abnormal liver function or Inflammation of the liver</p><p><strong>Very rare (Occurring in less than 1 in 10000 patients treated, including isolated cases)</strong></p><p>&bull;&nbsp;&nbsp;&nbsp; Reduced number of white blood cells, which may cause unexplained fever, sore throat, and flu-like symptoms.</p><p>&bull;&nbsp;&nbsp;&nbsp; Reduced number of blood platelets in blood, which may cause easy bruising or nasal bleeding.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Increase of the blood sugar level.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Pain or numbness in hands and feet.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the stomach lining, inflammation of the pancreas.</p><p>&bull;&nbsp;&nbsp;&nbsp; allergic reaction with swelling of the skin of face or extremities, swelling of lips or tongue, swelling of the mucous membranes in the mouth and throat, resulting in shortness of breath and difficulty to swallow. Contact an emergency room or a doctor immediately if this occurs.</p><p>&bull;&nbsp;&nbsp;&nbsp; In isolated cases allergic skin rash with irregular red spots, caused by medicines or severe allergic reactions with blistering eruptions of the skin and mucous membranes have been observed.</p><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Keep out of the reach and sight of children.<br />- Store below 30&deg;C.<br />- Do not use AMLOPRESS after the expiry date stated on the carton or label.<br />- Medicine should not be disposed of via wastewater or household waste.<br />Ask your pharmacist how to dispose of medicines no longer required. These<br />measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp; <strong>The active substance </strong>is Amlodipine. Each capsule contains either 5 mg of Amlodipine (as besilate).</p><p>-&nbsp;&nbsp;&nbsp;<strong> The other ingredients</strong> Microcrystalline Cellulose. Silicon dioxide, Mg stearate, Sodium starch glycollate, Calcium hydrogen phosphate, Gelatin capsule</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                AMLOPRESS 5mg comes as a Yellow and white color capsules filled with
White to off-white powder Coded by SJ 221 on one side and plain on the
other side
Pack of 28 Capsules.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>SAJA Pharmaceuticals</p><p>Saudi Arabian Japanese pharmaceutical company limited Jeddah - Saudi Arabia</p><p>To report any side effect(s)<br /><strong>&bull; Saudi Arabia</strong><br />- The National Pharmacovigilance Centre )NPC(:<br />- SFDA Call Center: 19999<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: https://ade.sfda.gov.sa<br /><br /><strong>&bull; Other GCC states /other countries</strong><br />-Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                August /2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي املوبرس إلى مجموعة من الأدوية تُسمى مضادات الكالسيوم.</p><p dir="RTL"><strong>يستخدم املوبرس لعلاج:</strong></p><p dir="RTL">- ارتفاع ضغط الدم.</p><p dir="RTL">- ألم الصدر الناتج عن ضيق الأوعية الدموية التي تُغذي عضلة القلب (الذبحة الصدرية) أو الشكل الأكثر ندرة من ألم الصدر الناتج عن تقلصات الأوعية الدموية بعضلة القلب.</p><p dir="RTL">إذا كنت تعاني من ارتفاع ضغط الدم، فإن املوبرس يعمل من خلال إرخاء (توسيع) الأوعية الدموية حتى يمر الدم خلالها بشكل أكثر سهولة.</p><p dir="RTL">إذا كنت تعاني من الذبحة الصدرية، فإن املوبرس يعمل من خلال تحسين تدفق الدم إلى عضلة القلب، وبالتالي تستقبل عضلة القلب المزيد من الأوكسجين وكنتيجة لذلك يتم منع حدوث ألم الصدر. لا يخفف املوبرس من ألم الصدر الناتج عن الذبحة الصدرية بشكل فوري.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول املوبرس، إذا كنت:</strong></p><p dir="RTL">- تعاني من حساسية تجاه املوبرس أو أحد حاصرات قنوات الكالسيوم؛ المشابهة (ما تسمى بمشتقات ديهيدروبيريدين مثل فيلوديبين، نيفيديبين، نيموديبين) أو أيٍّ من مكونات الأخرى (للاطلاع على قائمة المكونات الكاملة، انظر القسم 6).</p><p dir="RTL">- تعاني من صدمة قلبية. وهي حالة يكون القلب فيها غير قادر على ضخ كميات كافية من الدم إلى جميع أنحاء الجسم. أعراض الصدمة القلبية هي انخفاض ضغط الدم، وضعف النبض وتسارع ضربات القلب.</p><p dir="RTL">- تعاني من ضيق الشريان الأبهر (ضيق بالشريان الأورطي).</p><p dir="RTL">- تعاني من الم بالصدر أثناء الراحة أو عند بذل أقل مجهود (ذبحة صدرية غير مستقرة).</p><p dir="RTL">- حاملاً أو ترضّعين.</p><p dir="RTL">- تعاني من انخفاض شديد في ضغط الدم.</p><p dir="RTL"><strong>توخي حذرًا خاصًا عند تناول املوبرس</strong></p><p dir="RTL"><strong>قبل تناول املوبرس</strong>، أخبر الطبيب الخاص بك إذا:</p><p dir="RTL">- كنت تعاني من هبوط القلب (فشل القلب) أو قد عانيت من نوبة قلبية خلال الشهر الماضي.</p><p dir="RTL">- كنت تعاني من مشاكل في الكبد.</p><p dir="RTL">- كنت تعطي هذا الدواء لطفل عمره أقل من 18 عامًا.</p><p dir="RTL">- كنت من كبار السن، قد يقوم الطبيب الخاص بك بمتابعتك عن كثب.</p><p dir="RTL"><strong>تناوُل أدوية أخرى</strong></p><p dir="RTL">برجاء إبلاغ الطبيب أو الصيدلي الخاص بك إذا كنت تتناول أو تناولت مؤخرًا أية أدوية أخرى بما فيها الأدوية التي حصلت عليها دون وصفة طبية.</p><p dir="RTL">قد تتفاعل بعض الأدوية (بما فيها الأدوية التي تم الحصول عليها بدون وصفة طبية، وأدوية الأعشاب أو المنتجات الطبيعية) مع املوبرس. ويعني هذا إمكانية تغير طريقة عمل كلا الدوائين.</p><p dir="RTL">وبصفة خاصة، أخبر طبيبك إذا كنت تتناول أيّ من الأدوية التالية:</p><p dir="RTL">- الأدوية التي تُساعد على خفض ضغط الدم (مثل فيراباميل، ديلتيازيم).</p><p dir="RTL">- كيتوكونازول وإيتراكونازول (أدوية مضادة للفطريات تُستخدم لعلاج عدوى الجلد وعدوى الفطريات).</p><p dir="RTL">- مثبطات - إنزيم البروتياز بفيروس نقص المناعة البشرية (أدوية مضادة للفيروسات تُستخدم لعلاج عدوى فيروس نقص المناعة البشرية نمثل ريتونافير).</p><p dir="RTL">- كلاريثرومايسين، إيريثيرومايسين وتيليثرومايسين، ريفامبيسين، ريفابيوتين (مضادات حيوية).</p><p dir="RTL">- نيفازودون (دواء يُستخدم لعلاج الاكتئاب).</p><p dir="RTL">- نبتة سانت جونز (تسمى أيضًا هايبريكام برفوراتم؛ دواء عشبي يُستخدم لعلاج الاكتئاب).</p><p dir="RTL">- ديكساميثازون (أخد الكورتيكوستيرويدات التي تُستخدم لعلاج حالات المناعة الذاتية والالتهابات مثل التهاب المفاصل الروماتويدي).</p><p dir="RTL">- فينوباربيتالن فينيتوين وكاربامازيبين (أدوية لعلاج الصرع).</p><p dir="RTL">- نيفيرابين (دواء مضاد للفيروسات يُستخدم لعلاج عدوى فيروس نقص المناعة البشرية ومتلازمة نقص المناعة المكتسبة &quot;الإيدز&quot;).</p><p dir="RTL">- سيلدينافيل (دواء للضعف الجنسي).</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">تمت دراسة أمان وفعالية املوبرس في الذكور والإناث من سن 6 - 17 سنة. ولم تتم دراسة املوبرس في الأطفال أقل من 6 سنوات. إذا كنت بحاجة للمزيد من المعلومات، تحدث مع الطبيب الخاص بك.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تناول املوبرس مع الطعام والشراب</strong></p><p dir="RTL">يجب تناول املوبرس مع كوب من السوائل (مثل كوب من الماء) مع أو بدون طعام.</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">يجب عليكِ عدم تناول املوبرس إذا كنت حاملاً أو ترضّعين. إذا كنت في سن الحمل، يجب عليك التأكد من استخدام وسيلة منع حمل فعّالة أثناء العلاج. إذا أصبحتِ حاملاً أثناء تناول هذه الكبسولات، استشيري الطبيب الخاص بك على الفور.</p><p dir="RTL">استشيري الطبيب الخاص بك أو الصيدلي قبل تناول أي دواء.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">قد يعاني بعض المرضى من أعراض جانبية مثل: الدوار، والنعاس، وعدم وضوح الرؤية أثناء تناول هذه الكبسولات (انظر قسم 4 من هذه النشرة). من المحتمل أن تحدث تلك الأعراض الجانبية بشكل أكبر عند بدء العلاج أو بعد زيادة الجرعة. إذا كنت تعاني من هذه الأعراض الجانبية، يجب عليك عدم القيادة أو القيام بأنشطة أخرى تتطلب أن تكون يقظًا.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الجرعة</strong></p><p dir="RTL">تناول دائمًا املوبرس تمامًا كما وصف لك الطبيب الخاص بك. يجب عليك مراجعة الطبيب أو الصيدلي الخاص بك إذا لم تكن متأكدًا.</p><p dir="RTL"><strong>أساليب وطرق التناول</strong></p><p dir="RTL">قم بابتلاع املوبرس مع كوب من الماء، لا تقم بمضغها، يمكنك تناول الكبسول مع الطعام أو بدونه.</p><p dir="RTL"><strong>البالغون</strong></p><p dir="RTL">جرعة البدء المعتادة هي 5 ملج مرة واحدة يوميًا. قد يقوم طبيبك بزيادة الجرعة إلى 10 ملج مرة واحدة يوميًا إذا لزم الأمر.</p><p dir="RTL"><strong>الأطفال (من سن 6 - 17 سنة)</strong></p><p dir="RTL">جرعة البدء المعتادة الموصى بها هي 2.5 ملج يوميًا. أقصى جرعة موصى بها هي 5 ملج يوميًا.</p><p dir="RTL">املوبرس 2.5 ملج غير متاح حاليًا، ولا يمكن الحصول على الجرعة 2.5 ملج باستخدام 5 ملج و10 ملج حيث إن هذه الكبسولات غير مصنعة بطريقة تسمح بانقسامها إلى نصفين متساويين.</p><p dir="RTL"><strong>المرضى من كبار السن</strong></p><p dir="RTL">لا توجد جرعة خاصة لكبار السن؛ مع ذلك، يجب توخي الحذر عند زيادة الجرعة.</p><p dir="RTL"><strong>إذا كنت تعاني من مشاكل في الكُلى</strong></p><p dir="RTL">يُوصى بتناول الجرعة الطبيعية. لا يمكن إزالة املوبرس من الدم بواسطة الغسيل الكلوي (الكُلى الصناعية). يجب توخي حذرًا خاصًا عند إعطاء املوبرس للمرضى الذين يخضعون للغسيل الكلوي</p><p dir="RTL"><strong>إذا كنت تعاني من مشاكل في الكبد</strong></p><p dir="RTL">سيقرر الطبيب الخاص بك ما إذا كان هذا الدواء مناسبًا لك، كما سيقرر الجرعة الصحيحة لك.</p><p dir="RTL"><strong>إذا تناولت كمية من املوبرس أكثر مما يجب</strong></p><p dir="RTL">إذا تناولت أنت أو شخص آخر كمية كبيرة جدًا من املوبرس، اتصل بقسم الطوارئ في أقرب مستشفى. برجاء أخذ نشرة الدواء أو الكبسولات المتبقية معك حتى يتعرف الطبيب عليها بشكل أفضل. يجب أن يستلقي المريض على الأرض مع رفع الذراعين والساقين لأعلى (كأن يستند على وسادتين). أعراض زيادة الجرعة هي:</p><p dir="RTL">دوار مفرط و / أو شعور بدوخة شديدة، مشاكل في التنفس، الحاجة إلى التبول بشكل متكرر.</p><p dir="RTL">قـد يتراكـم سـائل زائـد فـي رئتيـك (وذمة ِرئوية) ممـا يسـبب ضيـق التنفـس الـذي قـد<br />يظهـر فـي غضـون 48-24سـاعة بعـد الاسـتهلاك.<br />&nbsp;</p><p dir="RTL"><strong>إذا نسيت أن تتناول املوبرس</strong></p><p dir="RTL">إذا نسيت تناوُل كبسولة املوبرس، يمكنك تناوله حتى 12 ساعة بعد موعده. إذا مر أكثر من 12 ساعة بعد الموعد الذي كان من المقرر أن تتناول فيه الكبسولة، فيجب عدم تناوله، ويجب تناول الكبسولة التالي في الموعد المعتاد. لا تتناول جرعة مضاعفة من املوبرس لتعويض الجرعة التي نسيتها.</p><p dir="RTL"><strong>إذا توقفت عن تناول املوبرس</strong></p><p dir="RTL">لقد أخبرك طبيبك بمدة تناول املوبرس إذا أوقفت العلاج فجأة، فقد تعود الأعراض التي كنت تعاني منها مرة أخرى. لا توقف العلاج قبل الموعد المتفق عليه دون مناقشة ذلك مع الطبيب الخاص بك.</p><p dir="RTL">يُستخدم املوبرس عادة للعلاج طويل المدى.</p><p dir="RTL"><strong>إذا كانت لديك أية أسئلة إضافية حول استخدام هذا الدواء، فاسأل الطبيب أو الصيدلي الخاص بك.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثله مثل جميع الأدوية، قد يُسبب املوبرس أعراضًا جانبية، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">أخبر طبيبك على الفور إذا عانيت من أيّ من الأعراض التالية عقب تناول هذا الدواء. على الرغم من ندرة هذه الأعراض، إلا أنها قد تكون شديدة وهي:</p><p dir="RTL">∙ أزيز مفاجئ بالصدر، صعوبة في التنفس، تورم الجفون، أو الوجه أو الشفتين، طفح جلدي أو حكة (خاصة التي تُؤثر على الجسم بأكمله).</p><p dir="RTL">أثناء العلاج باستخدام املوبرس تمت ملاحظة الأعراض الجانبية التالية:</p><p dir="RTL"><strong>شائعة جدًا (تحدث في أكثر من 1 من بين 10 مرضى تم علاجهم)</strong></p><p dir="RTL">∙ تورم الكاحلين.</p><p dir="RTL"><strong>شائعة (تحدث في أقل من 1 من بين 10 مرضى، لكن في أكثر من 1 من بين 100 مريض تم علاجهم).</strong></p><p dir="RTL">∙ صداع (خاصة عند بدء العلاج)، نعاس، دوار، ضعف.</p><p dir="RTL">∙ تسارع أو عدم انتظام ضربات القلب، غثيان، مشاكل في الهضم، ألم بالمعدة.</p><p dir="RTL">∙ احمرار الوجه والشعور بالسخونة (خاصة عند بدء العلاج).</p><p dir="RTL"><strong>غير شائعة (تحدث في أقل من 1 من بين 100 مريض، لكن في أكثر من 1 من بين 1.000 مريض تم علاجهم)</strong></p><p dir="RTL">∙ تضخم الثدي لدى الرجال.</p><p dir="RTL">∙ اضطرابات النوم، تهيج، اكتئاب.</p><p dir="RTL">∙ الشعور بأنك لست على ما يُرام، جفاف الفم، ارتجاف خارج عن السيطرة، الإحساس بوخز وشكشكة مثل الإبر والمسامير، زيادة التعرق.</p><p dir="RTL">∙ مشاكل في الرؤية (اضطرابات الرؤية).</p><p dir="RTL">∙ طنين أو دوي بالأذنين.</p><p dir="RTL">∙ إغماء، زيادة معدل ضربات القلب، ألم بالصدر، قد تتفاقم الذبحة الصدرية عند بدء العلاج.</p><p dir="RTL">∙ انخفاض ضغط الدم، التهاب الأوعية الدموية.</p><p dir="RTL">∙ صعوبات في التنفس، التهاب الغشاء المخاطي للأنف، سعال.</p><p dir="RTL">∙ قيء، إسهال، إمساك، تورم اللثّة.</p><p dir="RTL">∙ إحساس بوخز وتنميل في الجلد، حكة، طفح القراص، تساقط الشعر، تغير لون الجلد.</p><p dir="RTL">∙ تقلصات العضلات، ألم بالظهر، ألم بالعضلات والمفاصل.</p><p dir="RTL">∙ زيادة الحاجة إلى التبول.</p><p dir="RTL">∙ الضعف الجنسي، تضخم الثدي لدى الرجال.</p><p dir="RTL">∙ زيادة أو فقدان الوزن.</p><p dir="RTL"><strong>نادرة (تحدث في أقل من 1 من بين 1.000 مريض، لكن في أكثر من 1 من بين 10.000 مريض تم علاجهم)</strong></p><p dir="RTL">∙ ارتباك، تغير المزاج بما في ذلك القلق.</p><p dir="RTL">∙ تغيُّر بحاسة التذوق.</p><p dir="RTL">∙ ارتفاع بعض إنزيمات الكبد، اصفرار الجلد أو بياض العينين، قد يكون هذا نتيجة اختلال وظائف الكبد أو التهاب الكبد.</p><p dir="RTL"><strong>نادرة جدًا (تحدث في أقل من 1 من بين 10.000 مريض تم علاجهم، بما في ذلك الحالات الفردية)</strong></p><p dir="RTL">∙ انخفاض عدد كريات الدم البيضاء، مما قد يتسبب في حمى مجهولة السبب، والتهاب الحلق (احتقان)، وأعراض شبيهة بالأنفلونزا.</p><p dir="RTL">∙ انخفاض عدد الصفائح الدموية في الدم، الأمر الذي قد يتسبب في سهولة حدوث كدمات أو نزيف من الأنف.</p><p dir="RTL">∙ ارتفاع مستوى السكر في الدم.</p><p dir="RTL">∙ ألم أو خدر (تنميل) في اليدين والقدمين.</p><p dir="RTL">∙ التهاب بالغشاء المُبطِّن للمعدة، التهاب البنكرياس.</p><p dir="RTL">∙ تفاعل حساسية مع تورم جلد الوجه أو الأطراف، تورم الشفتين أو اللسان، تورم الأغشية المخاطية بالفم والحلق، مما يُؤدي إلى ضيق في التنفس وصعوبة في البلع. اتصل بغرفة الطوارئ أو أحد الأطباء على الفور في حالة حدوث ذلك.</p><p dir="RTL">∙ تمت ملاحظة حدوث طفح جلدي تحسسي (ناتج عن حساسية) مع بقع حمراء غير منتظمة، ذات منشأ دوائي أو تسببها تفاعلات حساسية شديدة مع ظهور بثور بالجلد والأغشية المخاطية في حالات فردية.</p><p dir="RTL"><strong>إذا أصبحت أيّ من الأعراض الجانبية خطيرة أو إذا لاحظت أية أعراض جانبية غير مدرجة في هذه النشرة، برجاء إبلاغ الطبيب أو الصيدلي الخاص بك.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">- ُيحفظ بعيدا عن متناول ورؤية الأطفال.<br />- يحفظ في درجة حرارة اقل من 30درجة مئوية.<br />- َ لا تستخدم الكبسولات بعد انتهاء تاريخ الصلاحية المدون على العبوة أو الملصق.<br />- يجـب عـدم التخلـص مـن الأدويـة عـن طريـق ميـاه الصـرف أو مـع المخلفـات المنزليـة.<br />استشــر الصيدلــي الخــاص بــك عــن كيفيــة التخلــص مــن الأدويــة التــي لــم تعــد بحاجــة<br />ُ إليهـا. ستسـاعد تلـك الإجـراءات فـي حمايـة البيئـة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>- المادة الفعّالة</strong> هي أملوديبين. يحتوي كل كبسولة على 5 ملج من أملوديبين (في صورة بيسيلات).<strong> </strong></p><p dir="RTL"><strong>المكونات الأخرى</strong> هي سليلوز فائق التبلور، ثاني أكسيد السيلكون، ستيرات المغنسيوم، جليكولات نشا الصوديوم، هيدروجين فوسفات الكالسيوم، كبسولة جيلاتينية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتوفــر الــدواء فــي هيئــة كبســولات جــزء منهــا باللــون الأصفــر والجــزء الأخــر باللــون<br />الأبيــض مملــوءة بمســحوق لونــه أبيــض منقــوش علــى احــد جانبيهــا SJ221<br />تحتوي العبوة على 28كبسولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مصنع ساجا للصناعات الدوائية</p><p dir="RTL">الشركة العربية السعودية اليابانية للمنتجات الصيدلانية المحدودة</p><p dir="RTL">جدة &ndash; المملكة العربية السعودية<strong>&nbsp;</strong></p><p dir="RTL">للإبلاغ عن أية آثار جانبية<br /><strong>&bull; المملكة العربية السعودية</strong><br />المركز الوطني للتيقظ والسلامة الدوائية<br />- مركز اتصالات الهيئة العامة للغذاء والدواء السعودية : 19999<br />npc.drug@sfda.gov.sa :- البريد الإلكتروني<br />https://ade.sfda.gov.sa :- الموقع الإلكتروني<br /><br /><strong>&bull; دول الخليج الأخرى/ الدول الأخرى</strong><br />- الرجاء الاتصال بالمؤسسات و الهيئات الوطنية في كل دولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            أغسطس /2023
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AMLOPRESS 5mg Capsule
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each Capsule contains 5mg of amlodipine (as Amlodipine besilate). Excipient(s): Cellulose. microcrystalline
For a full list of excipients see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AMLOPRESS 5mg comes as a Yellow and white color capsules filled with white to off white powder Coded by SJ 221 on one side and plain on the other side


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Essential hypertension.</p><p>Chronic stable and vasospastic angina pectoris.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In adults</p><p>For treatment of both hypertension and angina pectoris the usual initial dose is 5 mg once daily. If the desired therapeutic effect cannot be achieved within 2-4 weeks, this dose may be increased to a maximum dose of 10 mg daily (as single dose) depending on the individual patient&#39;s response. Amlodipine may be used either as monotherapy or in combination with other antianginal drugs in patients with angina.</p><p><em>Children with hypertension from 6 years to 17 years of age</em></p><p>The recommended antihypertensive oral dose in paediatric patients ages 6-17 years is 2.5 mg once daily as a starting dose, up-titrated to 5 mg once daily if blood pressure goal is not achieved after 4 weeks. Doses in excess of 5 mg daily have not been studied in paediatric patients (see section 5.1 Pharmacodynamic Properties and section 5.2 Pharmacokinetic Properties). The effect of amlodipine on blood pressure in patients less than 6 years of age is not known The 2.5 mg dose cannot be obtained with Amlodipine tablets 5 mg as these tablets are not manufactured to break into two equal halves.</p><p><em>In the elderly</em></p><p>Normal dosage regimens are recommended in the elderly, but caution should be exercised when increasing the dosage (see section 5.2 &quot;Pharmacokinetic properties&quot;). <em>In patients with renal impairment</em></p><p>In these patients amlodipine can be used in the normal dosage (see section 5.2 &quot;Pharmacokinetic properties&quot;). Amlodipine is not dialyzable.</p><p><em>In patients with hepatic impairment</em></p><p>A dosage regimen for patients with hepatic impairment has not been established, therefore amlodipine should be administered with caution (see section 4.4 &quot;Special warnings and precautions for use&quot;).</p><p>The tablets should be taken with a glass of water independently from meals.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Amlodipine is contra-indicated in patients with:
•	hypersensitivity to dihydropyridine derivates, amlodipine or any of the excipients
•	severe hypotension
•	shock (including cardiogenic shock)
•	haemodynamically unstable heart failure after acute myocardial infarction
•	Obstruction of the outflow tract of the left ventricle (e.g. high grade aortic stenosis)

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The safety and efficacy of amlodipine in hypertensive crisis has not been established. <em>Patients with cardiac failure</em></p><p>Patients with heart failure should be treated with caution. In a long-term, placebo controlled study in patients with severe heart failure (NYHA grade III and IV) the reported incidence of pulmonary oedema was higher in the amlodipine treated group than in the placebo group, but this was not associated with the worsening of the heart failure (see Section 5.1).</p><p><em>Use in patients with impaired hepatic function</em></p><p>The half-life of amlodipine is prolonged in patients with impaired liver function; dosage recommendations have not been established. Amlodipine should therefore be administered with caution in these patients.</p><p>&nbsp;</p><p><em>Use in elderly patients</em></p><p>In the elderly, increase of the dosage should take place with care (see Section 5.2).</p><p><em>Use in renal failure</em></p><p>Amlodipine may be used in such patients at normal doses. Changes in amlodipine plasma concentrations are not correlated with degree of renal impairment. Amlodipine is not dialysable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Effects of other medicinal products on amlodipine</u></p><p>CYP3A4 inhibitors: With concomitant use with the CYP3A4 inhibitor erythromycin in young patients and diltiazem in elderly patients respectively the plasma concentration of amlodipine increased by 22% and 50 % respectively. However, the clinical relevance of this finding is uncertain. It cannot be ruled out that strong inhibitors of CYP3A4 (i.e. ketoconazole, itraconazole, ritonavir) may increase the plasma concentrations of amlodipine to a greater extent than diltiazem. Amlodipine should be used with caution together with CYP3A4 inhibitors. However, no adverse events attributable to such interaction have been reported.</p><p>CYP3A4 inducers: There is no data available regarding the effect of CYP3A4 inducers on amlodipine. The concomitant use of CYP3A4 inducers (i.e. rifampicin, hypericum perforatum) may give a lower plasma concentration of amlodipine. Amlodipine should be used with caution together with CYP3A4 inducers.</p><p>In clinical interaction studies grapefruit juice, cimetidine, aluminium/magnesium (antacid) and sildenafil did not affect the pharmacokinetics of amlodipine.</p><p><u>Effects of amlodipine on other medicinal products</u></p><p>The blood pressure lowering effects of amlodipine adds to the blood pressure- lowering effects of other antihypertensive agents.</p><p>In clinical interaction studies, amlodipine did not affect the pharmacokinetics of atorvastatin, digoxin, ethanol (alcohol), warfarin or ciclosporin.</p><p>There is no effect of amlodipine on laboratory parameters.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy</p><p>The safety of amlodipine in human pregnancy has not been established. Reproductive studies in rats have shown no toxicity except for delayed date of delivery and prolonged duration of labour at dosages 50 times greater than the maximum recommended dosage for humans.</p><p>Use in pregnancy is only recommended when there is no safer alternative and when the disease itself carries greater risk for the mother and foetus.</p><p>Lactation</p><p>It is not known whether amlodipine is excreted in breast milk. A decision on whether to continue/discontinue breast-feeding or to continue/discontinue therapy with amlodipine should be made taking into account the benefit of breast-feeding to the child and the benefit of amlodipine therapy to the mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Amlodipine can have minor or moderate influence on the ability to drive and use machines. If patients taking amlodipine suffer from dizziness, headache, fatigue or nausea the ability to react may be impaired.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following undesirable effects have been observed and reported during treatment with amlodipine with the following frequencies: Very common ( <!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1032" type="#_x0000_t75" alt="GREATER-THAN OR EQUAL TO (8805)"
 style='width:9pt;height:9pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png"
  o:title="GREATER-THAN OR EQUAL TO (8805)"/>
</v:shape><![endif]--><img width="12" height="12" alt="GREATER-THAN OR EQUAL TO (8805)" src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" />1/10); common ( <!--[if gte vml 1]><v:shape
 id="_x0000_i1031" type="#_x0000_t75" alt="GREATER-THAN OR EQUAL TO (8805)"
 style='width:9pt;height:9pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png"
  o:title="GREATER-THAN OR EQUAL TO (8805)"/>
</v:shape><![endif]--><img width="12" height="12" alt="GREATER-THAN OR EQUAL TO (8805)" src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" />&nbsp;1/100 to &lt;1/10); uncommon ( <!--[if gte vml 1]><v:shape
 id="_x0000_i1030" type="#_x0000_t75" alt="GREATER-THAN OR EQUAL TO (8805)"
 style='width:9pt;height:9pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png"
  o:title="GREATER-THAN OR EQUAL TO (8805)"/>
</v:shape><![endif]--><img width="12" height="12" alt="GREATER-THAN OR EQUAL TO (8805)" src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" />1/1,000 to <!--[if gte vml 1]><v:shape
 id="_x0000_i1029" type="#_x0000_t75" alt="LESS-THAN OR EQUAL TO (8804)"
 style='width:9pt;height:9pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image003.png"
  o:title="LESS-THAN OR EQUAL TO (8804)"/>
</v:shape><![endif]--><img width="12" height="12" alt="LESS-THAN OR EQUAL TO (8804)" src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image004.gif" />1/100); rare ( <!--[if gte vml 1]><v:shape
 id="image1.png" o:spid="_x0000_i1028" type="#_x0000_t75" alt="GREATER-THAN OR EQUAL TO (8805)"
 style='width:9pt;height:9pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png"
  o:title="GREATER-THAN OR EQUAL TO (8805)"/>
</v:shape><![endif]--><img width="12" height="12" alt="GREATER-THAN OR EQUAL TO (8805)" src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" />1/10,000 to <!--[if gte vml 1]><v:shape
 id="_x0000_i1027" type="#_x0000_t75" alt="LESS-THAN OR EQUAL TO (8804)"
 style='width:9pt;height:9pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image003.png"
  o:title="LESS-THAN OR EQUAL TO (8804)"/>
</v:shape><![endif]--><img width="12" height="12" alt="LESS-THAN OR EQUAL TO (8804)" src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image004.gif" />1/1,000); very rare ( <!--[if gte vml 1]><v:shape
 id="image2.png" o:spid="_x0000_i1026" type="#_x0000_t75" alt="LESS-THAN OR EQUAL TO (8804)"
 style='width:9pt;height:9pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image003.png"
  o:title="LESS-THAN OR EQUAL TO (8804)"/>
</v:shape><![endif]--><img width="12" height="12" alt="LESS-THAN OR EQUAL TO (8804)" src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image004.gif" />1/10,000).</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>System Organ Class</p></td><td style="vertical-align:top"><p>Frequency</p></td><td style="vertical-align:top"><p>Undesirable effects</p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Leukocytopenia, thrombocytopenia</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Allergic reactions</p></td></tr><tr><td style="vertical-align:top"><p>Metabolism&nbsp;&nbsp;&nbsp;&nbsp; and&nbsp;&nbsp;&nbsp;&nbsp; nutrition disorders</p></td><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Hyperglycaemia</p></td></tr><tr><td style="vertical-align:top"><p>Psychiatric disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Insomnia, mood changes (including anxiety), depression</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Confusion</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Somnolence, dizziness, headache (especially at the beginning of the treatment)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Tremor,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dysgeusia,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; syncope, hypoesthesia, paresthesia</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Hypertonia, peripheral neuropathy</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Extrapyramidal disorder</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Visual disturbance (including diplopia)</p></td></tr><tr><td style="vertical-align:top"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Tinnitus</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Palpitations</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Myocardial infarction, arrhythmia (including bradycardia, ventricular tachycardia and aeterial fibrillation)</p></td></tr><tr><td style="vertical-align:top"><p>Vascular disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Flushing</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Hypotension</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Vasculitis</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory,&nbsp;&nbsp;&nbsp;&nbsp; thoracic&nbsp;&nbsp;&nbsp;&nbsp; and mediastinal disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Dyspnoea, rhinitis</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Cough</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Abdominal pain, nausea</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Vomiting, dyspepsia, altered bowel habits (including diaarhoea and constipation), dry mouth</p></td></tr></tbody></table><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Pancreatitis,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; gastritis,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; gingival hyperplasia</p></td></tr><tr><td style="vertical-align:top"><p>Hepato-biliary disorders</p></td><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Hepatitis, jaundice, hepatic enzymes increased*</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Alopecia, purpura, skin discolouration, hyperhydrosis, pruritus, rash, exanthema</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Angioedema, erythema multiforme, urticaria, exfoliative dermatitis, Stevens-Johnson syndrome, Quincke oedema, photosensitivity</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal,&nbsp;&nbsp;&nbsp; connective tissue and bone disorders</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Ankle swelling</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Arthralgia, myalagia, muscle cramps, back pain</p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Micturition&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disorder,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nocturia, increased urinary frequency</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive&nbsp;&nbsp;&nbsp;&nbsp; system&nbsp;&nbsp;&nbsp;&nbsp; and breast disorders</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Impotence, gynecomastia</p></td></tr><tr><td style="vertical-align:top"><p>General&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; disorders&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and administration site conditions</p></td><td style="vertical-align:top"><p>Very common</p></td><td style="vertical-align:top"><p>Oedema, fatigue</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Chest pain, asthenia, pain, malaise</p></td></tr><tr><td style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Weight increase, weight decrease</p></td></tr></tbody></table><p>*&nbsp; mostly consistent with cholestatis</p><p>--To report any side effect (s)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia :</strong></p><p><!--[if mso & !supportInlineShapes & supportFields]><span
style='font-size:10.0pt;mso-bidi-font-size:12.0pt'><span style='mso-element:
field-begin;mso-field-lock:yes'></span><span style='mso-spacerun:yes'> </span>SHAPE
<span style='mso-spacerun:yes'> </span>\* MERGEFORMAT <span style='mso-element:
field-separator'></span></span><![endif]--><!--[if gte vml 1]><v:shapetype id="_x0000_t202"
 coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
 <v:stroke joinstyle="miter"/>
 <v:path gradientshapeok="t" o:connecttype="rect"/>
</v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t202" style='width:408.75pt;
 height:63.55pt;mso-left-percent:-10001;mso-top-percent:-10001;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:char;
 mso-position-vertical:absolute;mso-position-vertical-relative:line;
 mso-left-percent:-10001;mso-top-percent:-10001' filled="f" strokeweight=".16969mm">
 <v:textbox inset="0,0,0,0">
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoBodyText style='margin-top:.95pt;margin-right:0in;margin-bottom:
    0in;margin-left:23.45pt;margin-bottom:.0001pt;text-indent:-18.05pt;
    mso-list:l0 level1 lfo1;tab-stops:23.45pt 23.5pt'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span>−<span
    style='letter-spacing:-.1pt'> </span>The<span style='letter-spacing:-.1pt'>
    </span>National<span style='letter-spacing:-.15pt'> </span>Pharmacovigilance<span
    style='letter-spacing:-.05pt'> </span>Center<span style='letter-spacing:
    -.1pt'> </span>(NPC)<o:p></o:p></p>
    <p class=MsoBodyText style='margin-left:23.45pt;text-indent:-18.05pt;
    mso-list:l0 level1 lfo1;tab-stops:23.45pt 23.5pt'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span>O<span
    style='letter-spacing:-.1pt'> </span>SFDA<span style='letter-spacing:-.05pt'>
    </span>Call<span style='letter-spacing:-.1pt'> </span>Center:<span
    style='letter-spacing:-.05pt'> </span>19999<o:p></o:p></p>
    <p class=MsoBodyText style='margin-left:23.45pt;text-indent:-18.05pt;
    mso-list:l0 level1 lfo1;tab-stops:23.45pt 23.5pt'><![if !supportLists]><span
    style='font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:
    Symbol'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span>O<span
    style='letter-spacing:-.2pt'> </span>E-mail:<span style='letter-spacing:
    -.15pt'> </span><a href="mailto:npc.drug@sfda.gov.sa"><span
    style='color:windowtext;text-decoration:none;text-underline:none'>npc.drug@sfda.gov.sa</span></a><o:p></o:p></p>
    <p class=MsoNormal style='margin-top:.05pt;margin-right:0in;margin-bottom:
    0in;margin-left:23.45pt;margin-bottom:.0001pt;text-indent:-18.05pt;
    mso-list:l0 level1 lfo1;tab-stops:23.45pt 23.5pt'><![if !supportLists]><span
    style='font-size:12.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
    mso-bidi-font-family:Symbol'><span style='mso-list:Ignore'>·<span
    style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </span></span></span><![endif]><span dir=LTR></span><span style='font-size:
    12.0pt;mso-bidi-font-size:11.0pt'>O<span style='letter-spacing:-.25pt'> </span>Website:<span
    style='letter-spacing:-.25pt'> </span></span>https://ade.sfda.gov.sa<o:p></o:p></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap type="none"/>
 <w:anchorlock/>
</v:shape><![endif]--><img width="551" height="91" alt="Text Box: •	− The National Pharmacovigilance Center (NPC)
•	O SFDA Call Center: 19999
•	O E-mail: npc.drug@sfda.gov.sa
•	O Website: https://ade.sfda.gov.sa
" src="file:///C:/Users/AMR~1.MAK/AppData/Local/Temp/msohtmlclip1/01/clip_image005.gif" /><!--[if mso & !supportInlineShapes & supportFields]><span
style='font-size:10.0pt;mso-bidi-font-size:12.0pt'><v:shape id="_x0000_i1025"
 type="#_x0000_t75" style='width:408.75pt;height:63.55pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p><p>&middot;&nbsp; &nbsp; &nbsp; &nbsp;&nbsp; <!--[if gte vml 1]></o:wrapblock><![endif]--><br />Other GCC states /other countries</p><p>-Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In humans, experience with intentional overdose is limited.</p><p><em>Symptoms:</em></p><p>Available data suggest that gross overdoseage could result in excessive peripheral vasodilatation and possibly reflex tachycardia. Marked and probably prolonged</p><p>&nbsp;</p><p>systemic hypotension up to and including shock with fatal outcome have been reported.</p><p>Non-cardiogenic pulmonary oedema has rarely been reported as a consequence of amlodipine overdose that may manifest with a delayed onset (24-48 hours post- ingestion) and require ventilatory support. Early resuscitative measures (including fluid overload) to maintain perfusion and cardiac output may be precipitating factors<br /><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><![endif]--><!--[if mso & !supportInlineShapes & supportFields]><span
style='font-size:10.0pt;mso-bidi-font-size:12.0pt'><v:shape id="_x0000_i1025"
 type="#_x0000_t75" style='width:415.35pt;height:58.65pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p><p><em>Treatment</em></p><p>Clinically significant hypotension due to amlodipine overdose calls for active cardiovascular support including frequent monitoring of cardiac and respiratory function, elevation of extremities, and attention to circulating fluid volume and urine output.</p><p>A vasoconstrictor may be helpful in restoring vascular tone and blood pressure, provided that there is no contraindication to its use. Intravenous calcium gluconate may be beneficial in reversing the effects of calcium channel blockade. Gastric lavage may be worthwhile in some cases. In healthy volunteers the use of charcoal up to 2hours after administration of amlodipine 10mg has been shown to reduce the absorption rate of amlodipine.</p><p>Since amlodipine is highly protein-bound, dialysis is not likely to be of benefit.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Dihydropyridine derivates</p><p>Amlodipine is a calcium antagonist and inhibits the influx of calcium ions into cardiac and smooth muscle cells. The mechanism of the antihypertensive action is due to the direct spasmolytic effect on vascular smooth muscle cells. The precise mechanism by which amlodipine relieves angina pectoris has not been fully determined, but the following two actions play a role:</p><p>1.&nbsp; Amlodipine dilates peripheral arterioles and thus reduces the peripheral resistance (afterload) against which the heart pumps. This unloading of the heart reduces myocardial energy consumption and oxygen requirements.</p><p>2.&nbsp;&nbsp; Dilatation of the main coronary arteries and the coronary arterioles also probably plays a role in its action. This dilation increases the supply in oxygen to myocardiac muscle in patients with Prinzmetal anginal attack.</p><p><em>Use in children</em></p><p>In a study involving 268 children aged 6-17 years with predominantly secondary hypertension, comparison of a 2.5mg dose, and 5.0mg dose of amlodipine with placebo, showed that both doses reduced Systolic Blood Pressure significantly more than placebo. The difference between the two doses was not statistically significant. The long-term effects of amlodipine on growth, puberty and general development have not been studied. The long-term efficacy of amlodipine on therapy in childhood to reduce cardiovascular morbidity and mortality in adulthood have also not been established.</p><p><em>Use in patients with hypertension</em>, once daily dosing provides clinically significant reductions of blood pressure (in both supine and standing positions) that persist for 24 hours.</p><p><em>Use</em><em> </em><em>in</em><em> </em><em>patients</em><em> </em><em>with</em><em> </em><em>angina pectoris</em>, once daily administration of amlodipine increases total exercise time, the delay of occurrence of anginal attack and the delay of the</p><p>&nbsp;</p><p>occurrence of a 1-mm ST interval. Amlodipine decreases both attack frequency and glyceryl trinitrate tablet consumption.</p><p><em>Use in Patients with Heart Failure</em></p><p>Haemodynamic studies and exercise based controlled clinical trials in NYHA Class II-IV heart failure patients have shown that amlodipine did not lead to clinical deterioration as measured by exercise tolerance, left ventricular ejection fraction and clinical symptomatology.</p><p>A placebo controlled study (PRAISE) designed to evaluate patients in NYHA Class III-IV heart failure receiving digoxin, diuretics and angiotensin-converting enzyme (ACE) inhibitors has shown that amlodipine did not lead to an increase in risk of mortality or combined mortality and morbidity in patients with heart failure.</p><p>In a follow-up, long-term, placebo controlled study (PRAISE-2) of amlodipine in patients with NYHA III and IV heart failure without clinical symptoms or objective findings suggestive of underlying ischaemic disease, on stable doses of ACE inhibitors, digitalis, and diuretics, amlodipine had no effect on total or cardiovascular mortality. In this same population amlodipine was associated with increased reports of pulmonary oedema despite no significant difference in the incidence of worsening heart failure as compared to placebo.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption/Distribution</p><p>After oral administration of therapeutic doses amlodipine is slowly absorbed from the gastrointestinal tract. The absorption of amlodipine is unaffected by the concomitant intake of food. The absolute bioavailability of the unchanged compound is estimated at 64-80%. Peak plasma levels are reached 6 to 12 hours post-dose. The volume of distribution is about 20 l/kg. The pKa of amlodipine is 8.6. Plasma protein binding in vitro is approximately 98%.</p><p><em>Metabolism/Elimination</em></p><p>The plasma elimination half-life is about 35 to 50 hours.</p><p>Steady state plasma levels are reached after 7-8 consecutive days.</p><p>Amlodipine is predominantly metabolised to inactive metabolites. About 60% of the administered dose is excreted in the urine, about 10% of which in the form of unchanged amlodipine.</p><p><em>Use in Elderly</em></p><p>The time to reach peak plasma concentrations of amlodipine is similar in elderly and younger subjects. Amlodipine clearance tends to be decreased with resulting increases in AUC and elimination half life in elderly patients. Increases in AUC and elimination half life in patients with congestive heart failure were as expected for the patient age group in this study (See Section 4.4).</p><p><em>In patients with impaired renal function</em></p><p>Amlodipine is extensively biotransformed to inactive metabolites. Ten percent of the substance is excreted unchanged in the urine. Changes in amlodipine plasma concentration are not correlated with the degree of renal impairment. In these patients amlodipine may be administered at the normal dosage. Amlodipine is not dialysable.</p><p><em>Patients with hepatic impairment</em></p><p>The half-life of amlodipine is prolonged in patients with impaired hepatic function.</p><p><em>Use in children</em></p><p>&nbsp;</p><p>A population PK study has been conducted in 74 hypertensive children aged from 1 month to 17 years (with 34 patients aged 6 to 12 years and 28 patients aged 13 to 17 years) receiving amlodipine between 1.25 and 20 mg given either once or twice daily. In children 6 to 12 years and in adolescents 13-17 years of age the typical oral clearance (CL/F) was 22.5 and 27.4 L/hr respectively in males and 16.4 and 21.3 L/hr respectively in females. Large variability in exposure between individuals was observed. Data reported in children below 6 years is limited.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and carcinogenic potential. In animal studies with respect to the reproduction in rats at high doses delayed parturition, difficult labour and impaired foetal and pup survival were seen (see Section 4.6 &quot;Pregnancy and Lactation&quot;).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cellulose. microcrystalline. Silicon dioxide, Mg stearate, Sodium starch glycolate, Calcium hydrogen phosphate, Gelatin capsule.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                4 Years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PVC-PVDC/Aluminum blister pack</p><p>Pack of 28 Capsules.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SAJA Pharmaceuticals
Saudi Arabian Japanese pharmaceutical company limited Jeddah – Saudi Arabia

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Aug.2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>